BM

BeOne Medicines at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

BeOne Medicines at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
BM
BeOne Medicines
Large pharma
Oncology company, formerly BeiGene, developing and marketing cancer medicines including the BTK inhibitor zanubrutinib.
Panel
Tue Nov 10
15:30–15:55
Unlocking Europe as a Clinical Trials Hub: Delivering Trials at Scale Through Strategic Site Optimization and Operational Excellence
How to run large clinical trials across Europe's varied health systems, from picking trial sites to faster study start-up and cross-border logistics.
with Optimapharm

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from BeOne Medicines

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction